DalCor Pharmaceuticals
PrivateLast Round
Seed Round
Aug 28, 2026
Total Funding Raised
$230M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DalCor Pharmaceuticals is a biopharmaceutical company that develops dalcetrapib, a pharmacogenetic precision medicine for cardiovascular disease that specifically targets patients with the ADCY9 AA genotype.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DalCor Pharmaceuticals Comparables
Compare DalCor Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cardurion Pharmaceuticals | 71% | |
| Abcentra | 68% | |
| Novo Nordisk | 67% | |
DalCor Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 28, 2026 | ||||
| Series D | Sep 13, 2023 | ||||
| Series B | Apr 19, 2016 | ||||
| Series A | Nov 1, 2015 |
Key People
Founding team and executive leadership
DalCor Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Series D |
| CTI Life Sciences Fund | Series D, Series B |
| Investissement Québec | Series D |
| Fonds de solidarité FTQ | Series D, Series B |
| Caisse de dépôt et placement du Québec | Series B |
| Caisse de dépôt et placement du Québec | Series B |
| Sanderling Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
$7M round raised
DalCor Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DalCor Pharmaceuticals's valuation, stock price, and market status.